# Roll-over After 3-year Trial for Tenofovir in Mild Chronic Hepatitis B

> **NCT02463019** · PHASE4 · UNKNOWN · sponsor: **E-DA Hospital** · enrollment: 160 (estimated)

## Conditions studied

- Chronic Hepatitis B
- Antiviral Treatment

## Interventions

- **DRUG:** Tenofovir Disoproxil Fumarate

## Key facts

- **NCT ID:** NCT02463019
- **Lead sponsor:** E-DA Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-01
- **Primary completion:** 2019-01
- **Final completion:** 2020-01
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2015-06-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02463019

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02463019, "Roll-over After 3-year Trial for Tenofovir in Mild Chronic Hepatitis B". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02463019. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*